XNAS: ERNA
Eterna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the ...
Read More
6.04
2.05
(51.38%)
63.8M
XNAS Volume
High volume+gain today
XNAS 06 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Eterna Therapeutics Inc is scheduled for today, for the purpose of Ernexa Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Eterna Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..